DES Action USA P.O. Box 7296 Jupiter, FLwww.desaction.org; Serving the DES-exposed community since 1978

First Page		Document Content
Date: 2015-03-31 19:32:07 Sexual arousal Sexual health Female reproductive system Non-sexuality Diethylstilbestrol Eli Lilly and Company Hypoactive sexual desire disorder Sexual dysfunction Flibanserin Human sexuality Reproductive system Human behavior		DES Action USA P.O. Box 7296 Jupiter, FLwww.desaction.org; Serving the DES-exposed community since 1978 Add to Reading List Source URL: www.desaction.org Download Document from Source Website File Size: 85,55 KB Share Document on Facebook

	ADDYI (flibanserin) tablets LABEL DocID: 1t188 - View Document
	STATEMENT OF Peggy Barksdale, President National Association of Clinical Nurse Specialists on The Food and Drug Administration’s Approval of Flibanserin DocID: 1mvur - View Document
	15 REVIEW Multifunctional Pharmacology of Flibanserin: Possible Mechanism of Therapeutic Action in Hypoactive Sexual Desire Disorder jsm_2032 DocID: 1jByi - View Document
	DES Action USA P.O. Box 7296 Jupiter, FLwww.desaction.org; Serving the DES-exposed community since 1978 DocID: 18PnH - View Document
	Microsoft Word - ISSWSH FDA.docx DocID: 15G7Z - View Document